Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Feb 21, 2017; 23(7): 1262-1267
Published online Feb 21, 2017. doi: 10.3748/wjg.v23.i7.1262
Table 1 Baseline demographic and clinical characteristics of study patients n (%)
Total patientsSurvivorsNon-survivorsP value
(n = 23)(n = 13)(n = 10)
Age, yr61.0 (51.0-66.0)61.0 (53.0-69.0)52.0 (38.0-62.0)0.74
Male11 (48)6 (46)5 (50)0.86
Comorbidities
Hypertension6 (26)5 (38)1 (10)0.11
Diabetes mellitus2 (9)2 (17)0 (0)0.17
Chronic kidney disease0 (0)0 (0)0 (0)
Chronic liver disease0 (0)0 (0)0 (0)
Time from ingestion to hospitalization, d3.0 (3.0-3.0)3.0 (3.0-3.0)3.0 (3.0-3.0)0.26
Vital signs, initial
SBP, mmHg126.0 (112.0-134.0)122.0 (116.0-133.0)128.5 (112.0-146.0)0.47
DBP, mmHg71.0 (66.0-89.0)78.0 (67.0-90.0)69.5 (66.5-77.5)0.59
Heart rate, min78.0 (65.0-89.0)70.0 (63.0-87.0)94.5 (78.5-116.2)0.03
Respiratory rate, min20.0 (18.0-20.0)20.0 (18.0-20.0)20.0 (20.0-20.0)0.24
Temperature, °C36.6 (36.1-37.1)36.6 (36.2-36.1)36.6 (36.1-37.0)0.56
SpO2, %98.0 (97.0-99.0)98.0 (97.0-99.0)98.0 (97.0-99.0)0.36
Laboratory data
WBC, × 103/mL7.5 (5.8-12.2)7.0 (6.0-8.3)11.3 (6.0-15.6)0.11
Hemoglobin, g/dL14.1 (13.0-15.4)14.2 (13.4-15.4)12.8 (10.6-15.0)0.12
Platelet, × 103/mL172.0 (115.0-223.0)197.0 (156.0- 223.0)125.5 (87.3-181.3)0.06
BUN, mg/dL21.0 (9.0-33.0)15.0 (10.0-29.0)23.0 (10.3-31.5)0.66
Cr, mg/dL0.90 (0.60-1.30)0.70 (0.60-0.90)1.70 (1.00-1.80)0.23
AST, IU/L4568.0 (863.0-6933.0)4568.0 (702.0-5471.0)5650.0 (2065.3-8155.8)0.19
ALT, IU/L4750.0 (1561.0-5543.0)4436.0 (1561.0-5543.0)5002.0 (2235.5-6584.3)0.31
γ-GT, IU/L38.0 (23.0-71.0)26.0 (13.0-53.0)55.50 (39.0-85.0)0.35
ALP, IU/L85.0 (71.0-162.0)71.0 (69.0-81.0)165.0 (151.0-208.0)< 0.01
Total bilirubin, mg/dL3.50 (1.70-6.40)1.80 (1.60-3.00)6.80 (6.00-8.80)< 0.01
Indirect/direct bilirubin ratio1.79 (0.5-3.08)2.45 (1.06-3.84)0.99 (0.54-1.44)< 0.01
PT-INR, s2.90 (1.40-8.80)1.60 (1.20-2.60)9.70 (7.60-14.30)< 0.01
aPTT, s41.4 (28.9-54.3)29.1 (28.9-35.3)54.6 (52.6-71.4)0.01
Management
Vasopressor7 (30)0 (0)7 (70)< 0.01
Mechanical ventilation6 (26)0 (0)6 (60)< 0.05
CRRT5 (22)0 (0)5 (50)< 0.01
Table 2 Odds ratios for poor outcomes in patients
OR95%CIP value
Alkaline phosphatase1.21(0.91, 1.60)0.20
Total bilirubin3.58(1.25, 10.22)0.02
Indirect/direct bilirubin ratio0.13(0.02, 0.94)0.04
Prothrombin time789.00-0.98
Activated partial thromboplastin time1.30(1.04, 1.63)0.02